SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001863113-21-000002
Filing Date
2021-07-07
Accepted
2021-07-07 17:00:33
Documents
1
Period of Report
2021-05-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4084
  Complete submission text file 0001863113-21-000002.txt   5542
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Issuer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELITE PHARMACEUTICALS, INC. 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address
Bregman Marc (Reporting) CIK: 0001863113 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15697 | Film No.: 211077996